On Oct. 1, Pfizer agreed to lower the prices of some drugs in response to President Donald Trump’s executive order on most favored nation drug pricing.
Pfizer’s stock surged after CEO Albert Bourla announces an agreement with the Trump administration aimed at lowering drug prices in the U.S. and removing tariff uncertainty.
Zacks Investment Research on MSN
Bright Minds Biosciences Inc. (DRUG) is on the Move, Here's Why the Trend Could be Sustainable
While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the ...
The House of Representatives overwhelmingly approved a bill Thursday classifying the powerful opiate fentanyl as among the most dangerous drugs — opening the door to traffickers facing mandatory ...
Police have smashed a drug ring involving huge quantities of heroin and fentanyl that were packaged at underground “mills” in Passaic and Bergen counties, state Attorney General Matthew J. Platkin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback